​

Funding Round

Series B - AltPep

Series B - AltPep

Investment Firm

Overview

AltPep provides a novel approach for tackling amyloid diseases, with diagnostic, therapeutic and anti-biofilm applications.

Announced Date

Jun 22, 2023

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Senator Investment Group

Senator Investment Group

No designation

Participant Investors

5

Investor Name
Participant InvestorPartners Investment
Participant InvestorAlexandria Venture Investments
Participant InvestorSenator Investment Group
Participant InvestorEli Lilly
Participant InvestorSection 32

Round Details and Background

AltPep raised $52900000 on 2023-06-22 in Series B

AltPep provides a novel approach for tackling amyloid diseases, with diagnostic, therapeutic and anti-biofilm applications.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 12, 2021
Series A - AltPep
2-23.1M
Jun 22, 2023
Series B - AltPep
6-52.9M

Recent Activity

There is no recent news or activity for this profile.